RE:RE:RE:RE:RE:RE:3 days of insider SELLING!Insider sell is probably wrong, same issue also happened before. SEDAR is the most reliable source for this info and insiders should be in a black out period and not able to sell or buy.
Gestys's sell is strange if the deal is so close they should not try to reduce position for whatever reason. Except management's claims I do not see any sign that we would get a deal before year end. We should be near 52w highs now in an ideal case.
There is no shareholder value created in the last 3 years and I will say it again only salary costs could have been enough to conduct a trial up to market approval stage. Without data of course big pharma would ask for future tests and more. Same is also valid for keloid and others , doing few in vitro tests is not convincing enough and there is still risk of failure. I am pretty sure if they had data on human like before - after with clear skin color change it would have been more convincing for everybody.
People always refer to the potential, this potential has been there for more than 4 years and there was not any solid outcome of it. They have attended tons of meetings and there is no institutional holding for more than 10% of shares. With videos and updates they were only able to convince small investors like us no big buyer came for years.
If the deal is close why management can not convince any big buyer to get in?